Pharmacist Registrant 34 has satisfied the terms of a Consent Agreement reached with the Inquiry Committee on April 28, 2021. The pharmacist registrant’s name has been withheld pursuant to s. 39.3(4) of the Health Professions Act.
April 28, 2021
(March 4, 2022 - Limits and conditions removed)
Pursuant to Section 36(1) of the Health Professions Act, the Inquiry Committee has reached a new Agreement with the pharmacist registrant whereby the registrant consented to terms including, but not limited to, the following:
- To comply with any and all recommendations and treatment prescribed or directed by the physician; and
- To attend regular appointments with the physician and comply with random monitoring.
This Agreement will remain in place until such a time as the pharmacist registrant is reassessed and further recommendations to continue or terminate appointments and/or random monitoring are made by the physician. The name of the pharmacist registrant has been withheld in accordance with Section 39.3(4) of the Health Professions Act.
May 6, 2020
(April 28, 2021 - Limits and Conditions Updated)
Pursuant to Section 36(1) of the Health Professions Act, the Inquiry Committee has reached a new Agreement with the pharmacist registrant whereby the registrant consented to terms including, but not limited to, the following:
- To comply with any and all recommendations and treatment prescribed or directed by the physician; and
- To attend group meetings, consultations with specialists, and regular monitoring for a period of once year.
This Agreement will remain in place until such a time as the pharmacist registrant is reassessed and further recommendations to continue or terminate consultations and/or regular monitoring are made by the physician. The name of the pharmacist registrant has been withheld in accordance with Section 39.3(4) of the Health Professions Act.
July 4, 2018
(May 6, 2020 - Limits and Conditions Updated)
The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously be suspended for an indefinite period on February 10, 2018. Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings. The undertakings include, but are not limited to:
- The Registrant will comply with any and all recommendations and treatment prescribed or directed by physician; and
- The Registrant will follow a regular monitoring program for medical condition for a two year period.
The Agreement will remain in place until such time as the Registrant’s physician states otherwise. The name of the Registrant has been withheld in accordance with section 39.3(4) and (6) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant. The Inquiry Committee is satisfied that the undertakings will protect the public.
February 10, 2018
(July 4, 2018 - Registration reinstated)
The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with pharmacist registrant to suspend registration as a pharmacist for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.